OJEM  Vol.5 No.3 , September 2017
Bromocriptine in Central Hyperthermia after Severe Traumatic Brain Injury
Abstract: Strong evidence showed that fever after traumatic brain injury TBI is associated with increased mortality. In this study, we tried to evaluate the role of Bromocriptine in central hyperthermia in patients with severe TBI. This prospective controlled study was conducted on 50 severe TBI patients who admitted to the critical care department and confirmed on Computed Tomography (CT) of the brain and GCS of less than 9 at admission. Then, they were randomly assigned into 2 groups. Bromocriptine group (25) received bromocriptine 7.5 mg/day during 24 hours from admission through a naso-gastric (NG) feeding tube. Control group (25) received conventional treatment only. Temperature was measured every 2 hours. The antipyretic measures used were the same across all patients enrolled. The primary outcome was number of patients diagnosed with central hyperthermia. After the discharge of all patients, there was a statistically significant difference between the 2 groups in number of patients diagnosed with central hyperthermia (6 (24%) in bromocriptine group Vs 18 (72%) in control, p = 0.002). There were no differences in hospital length of stay (p = 0.904) or mortality (p = 0.393). Early administration of bromocriptine in severe TBI may be associated with lower incidence of central hyperthermia with no effect on length of stay or mortality.
Cite this paper: Zakhary, T. and Sabry, A. (2017) Bromocriptine in Central Hyperthermia after Severe Traumatic Brain Injury. Open Journal of Emergency Medicine, 5, 102-109. doi: 10.4236/ojem.2017.53010.

[1]   VA/DoD (2009) Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury. Journal of Rehabilitation Research and Development, 46, 1-68.

[2]   Teasdale, G. and Jennett, B. (1974) Assessment of Coma and Impaired Consciousness: A Practical Scale. The Lancet, 304, 81-84.

[3]   Georgilis, K., Plomaritoglou, A., Dafni, U., Bassiakos, Y. and Vemmos, K. (1999) Aetiology of Fever in Patients with Acute Stroke. Journal of Internal Medicine, 246, 203-209.

[4]   Roth, E.J., Love, L.L.L., Harvey, R.L., Heinemann, A.W., Semik, P. and Diaz, S. (2001) Incidence of and Risk Factors for Medical Complications during Stroke Rehabilitation. Stroke, 32, 523-529.

[5]   Circiumaru, B., Baldock, G. and Cohen, J.A. (1999) Prospective Study of Fever in the Intensive Care Unit. Intensive Care Medicine, 25, 668-673.

[6]   Lakhan, S.E. and Pamplona, F. (2012) Application of Mild Therapeutic Hypothermia on Stroke: A Systematic Review and Meta-Analysis. Stroke Research and Treatment, 2012, Article ID: 295906.

[7]   Castillo, J., Dávalos, A., Marrugat, J. and Noya, M. (1998) Timing for Fever-Related Brain Damage in Acute Ischemic Stroke. Stroke, 29, 2455-2460.

[8]   Sung, C.Y., Lee, T.H. and Chu, N.S. (2009) Central Hyperthermia in Acute Stroke. European Neurology, 62, 86-92.

[9]   Saper, C.B., Lu, J., Chou, T.C. and Gooley, J. (2005) The Hypothalamic Integrator for Circadian Rhythms. Trends in Neurosciences, 28, 152-157.

[10]   Crompton, M.R. (1971) Hypothalamic Lesions Following Closed Head Injury. Brain, 94, 165-172.

[11]   Zimmerman, H. (1940) Temperature Disturbances and the Hypothalamus. Research Publications—Association for Research in Nervous and Mental Disease, 20, 824-840.

[12]   Davison, C. (1940) Disturbances of Temperature Regulation in Man. Research Publications—Association for Research in Nervous and Mental Disease, 20, 774-823.

[13]   Rango, M., Arighi, A., Airaghi, L. and Bresolin, N. (2012) Central Hyperthermia, Brain Hyperthermia and Low Hypothalamus Temperature. Clinical Autonomic Research, 22, 299-301.

[14]   Bernheim, H., Block, L. and Atkins, E. (1979) Fever: Pathogenesis, Pathophysiology, and Purpose. Annals of Internal Medicine, 91, 261-270.

[15]   Badjatia, N. (2009) Fever Control in the Neuro-ICU: Why, Who, and When? Current Opinion in Critical Care, 15, 79-82.

[16]   Rincon, F., Patel, U., Schorr, C., Lee, E., Ross, S., Dellinger, R.P., et al. (2015) Brain Injury as a Risk Factor for Fever upon Admission to the Intensive Care Unit and Association with In-Hospital Case Fatality: A Matched Cohort Study. Journal of Intensive Care Medicine, 30, 107-114.

[17]   Moltz, H. (1993) Fever: Causes and Consequences. Neuroscience & Biobehavioral Reviews, 17, 237-269.

[18]   Fernandez, A., Schmidt, J., Claassen, J., Pavlicova, M., Huddleston, D., Kreiter, K., et al. (2007) Fever after Subarachnoid Hemorrhage Risk Factors and Impact on Outcome. Neurology, 68, 1013-1019.

[19]   Saxena, M., Young, P., Pilcher, D., Bailey, M., Harrison, D., Bellomo, R., et al. (2015) Early Temperature and Mortality in Critically Ill Patients with Acute Neurological Diseases: Trauma and Stroke Differ from Infection. Intensive Care Medicine, 41, 823-832.

[20]   Diringer, M.N., Reaven, N.L., Funk, S.E. and Uman, G.C. (2004) Elevated Body Temperature Independently Contributes to Increased Length of Stay in Neurologic Intensive Care Unit Patients. Critical Care Medicine, 32, 1489-1495.

[21]   Greer, D.M., Funk, S.E., Reaven, N.L., Ouzounelli, M. and Uman, G.C. (2008) Impact of Fever on Outcome in Patients with Stroke and Neurologic Injury. Stroke, 39, 3029-3035.

[22]   Olanow, C.W. and Koller, W.C. (1998) An Algorithm (Decision Tree) for Themanagement of Parkinson’s Disease Treatment Guidelines. Neurology, 50, S1-S88.

[23]   McEvoy, G.K. (2000) AHFS Drug Information. American Society of Health-System Pharmacists.

[24]   Yu, K.-W., Huang, Y.-H., Lin, C.-L., Hong, C.-Z. and Chou, L.-W. (2013) Effectively Managing Intractable Central Hyperthermia in a Stroke Patient by Bromocriptine: A Case Report. Neuropsychiatric Disease and Treatment, 9, 605.

[25]   Samudra, N. and Figueroa, S. (2016) Intractable Central Hyperthermia in the Setting of Brainstem Hemorrhage. Therapeutic Hypothermia and Temperature Management, 6, 98-101.

[26]   Meier, K. and Lee, K. (2017) Neurogenic Fever: Review of Pathophysiology, Evaluation, and Management. Journal of Intensive Care Medicine, 32, 124-129.

[27]   Rabinstein, A.A. (2007) Paroxysmal Sympathetic Hyperactivity in the Neurological Intensive Care Unit. Neurological Research, 29, 680-682.

[28]   Deogaonkar, A., De Georgia, M., Bae, C., Abou-Chebl, A. and Andrefsky, J. (2005) Fever Is Associated with Third Ventricular Shift after Intracerebral Hemorrhage: Pathophysiologic Implications. Neurology India, 53, 202.

[29]   Kang, S.H., Kim, M.J., Shin, I.Y., Park, D.W., Sohn, J.W. and Yoon, Y.K. (2012) Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report. Journal of Korean Medical Science, 27, 965-968.

[30]   Russo, R. and O’Flaherty, S. (2000) Bromocriptine for the Management of Autonomic Dysfunction after Severe Traumatic Brain Injury. Journal of Paediatrics and Child Health, 36, 283-285.

[31]   Bullard, D.E. (1987) Diencephalic Seizures: Responsiveness to Bromocriptine and Morphine. Annals of Neurology, 21, 609-611.

[32]   Frenette, A.J., Kanji, S., Rees, L., Williamson, D.R., Perreault, M.M., Turgeon, A.F., et al. (2012) Efficacy and Safety of Dopamine Agonists in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials. Journal of Neurotrauma, 29, 1-18.

[33]   Munakomi, S., Bhattarai, B. and Mohan Kumar, B. (2017) Role of Bromocriptine in Multi-Spectral Manifestations of Traumatic Brain Injury. Chinese Journal of Traumatology, 20, 84-86.

[34]   Phelps, T.I., Bondi, C.O., Ahmed, R.H., Olugbade, Y.T. and Kline, A.E. (2015) Divergent Long-Term Consequences of Chronic Treatment with Haloperidol, Risperidone, and Bromocriptine on Traumatic Brain Injury-Induced Cognitive Deficits. Journal of Neurotrauma, 32, 590-597.